- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
The squeeze is on these stocks, and they are poised for volatile moves.
Despite tepid market reaction, and analyst skepticism, there might be some upside for TMO.
Thermo Fisher Scientific (TMO) has reportedly offered $30 billion to acquire Illumina (ILMN).